Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00323063
What this trial is testing

Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 49
Testing effectiveness (Phase 2)Looking for participantsNCT04990921
What this trial is testing

Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University of Louisville 15
Very early researchLooking for participantsNCT05704283
What this trial is testing

3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer

Who this might be right for
Breast Carcinoma
Mayo Clinic 55
Testing effectiveness (Phase 2)Study completedNCT00052351
What this trial is testing

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Not applicableUnknownNCT03025139
What this trial is testing

Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)

Who this might be right for
Cancer SurvivorEarly-Stage Breast CarcinomaStage 0 Breast Cancer+7 more
Jonsson Comprehensive Cancer Center 96
Testing effectiveness (Phase 2)WithdrawnNCT00397501
What this trial is testing

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more
OHSU Knight Cancer Institute
Early research (Phase 1)WithdrawnNCT05905341
What this trial is testing

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Who this might be right for
Breast CancerOvarian CancerLiposarcoma+3 more
Pfizer
Not applicableStudy completedNCT06035731
What this trial is testing

Evaluation of the Medical Service by Socio-aesthetics in Oncology

Who this might be right for
Cancer of ColonCancer, LungCancer, Breast+3 more
Centre Hospitalier de Valence 400
Early research (Phase 1)Study completedNCT00623831
What this trial is testing

Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

Who this might be right for
MelanomaSarcomaGastrointestinal Stromal Tumor (GIST)+6 more
Ludwig Institute for Cancer Research 17
Testing effectiveness (Phase 2)Study completedNCT00083031
What this trial is testing

Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 57
Not applicableStudy completedNCT05510037
What this trial is testing

Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic Lesions

Who this might be right for
Breast Cancer
Fudan University 1,299
Not applicableStudy completedNCT04330339
What this trial is testing

Prolonged Nightly Fasting in Breast Cancer Survivors

Who this might be right for
FastingBreast CancerSurvivorship+1 more
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06324357
What this trial is testing

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Who this might be right for
Metastatic Breast CancerMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Boehringer Ingelheim 768
Not applicableStudy completedNCT07332754
What this trial is testing

Retrospective Observational Study on the Use of Advanced Bacterial-binding Dressings (DACC-coated Hydrogel Dressings) in Radiodermatitis

Who this might be right for
Radiodermatitis; Acute
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 18
Very early researchUnknownNCT02719795
What this trial is testing

Pectoral Nerves Blocks for Chronic Pain

Who this might be right for
Breast Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 140
Large-scale testing (Phase 3)Study completedNCT02019277
What this trial is testing

Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 50
Testing effectiveness (Phase 2)Ended earlyNCT01891357
What this trial is testing

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

Who this might be right for
Carcinoma, Ductal, Breast
Women's Cancer Study Group GmbH 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05983094
What this trial is testing

Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer

Who this might be right for
Breast CancerNeoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 181
Not applicableStudy completedNCT04112966
What this trial is testing

Lymphedema Prevention in Breast Cancer

Who this might be right for
Breast CancerLymphedema
University of Castilla-La Mancha 150
Early research (Phase 1)Study completedNCT00128622
What this trial is testing

Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
H. Kim Lyerly 24
Next Page